Showing results (531-540 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 4, 2026
Comparison of induction chemotherapy with/without PD-1 inhibitors followed by concurrent chemoradiotherapy in locally advanced head and neck squamous cell carcinomaYongchao Yu, Zan Jiao, Tong Wu, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1984
Stage-related decrease in natural killer cell activity in untreated patients with mycosis fungoidesS Levy, J L Tempé, P Caussade, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
Functional consequence of variation in melanoma antigen expressionL M Zehngebot, M A Alexander, D Guerry, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitizationA Mazumder, E A Grimm, S A RosenbergCancer Immunology, Immunotherapy : CII|January 1, 1984
Augmentation of antitumor resistance by a strain of unicellular green algae, Chlorella vulgarisK Tanaka, F Konishi, K Himeno, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1984
Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studiesB Nardelli, P Puccetti, L Romani, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1984
Selective macrophage activation by muramyldipeptide bound to monoclonal antibodies specific for mouse tumor cellsA C Roche, P Bailly, P Midoux, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1982
In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated ratsT Ogura, H Shindo, O Shinzato, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1982
Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factorT Maier, J G LevyCancer Immunology, Immunotherapy : CII|January 1, 1982
Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigenT Tanaka, H Yamagishi, N R Pellis, et al.Pageof 650